Importantly, both studies report a significant and sustained increase of ANP in subjects receiving sacubitril/valsartan, which further support the concept that augmenting ANP circulating levels has a beneficial effect in the long-term treatment of cardiovascular diseases. The gene discussed is NPPA; the disease is cardiovascular disorder.